Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
      Description

      This is a study designed to determine if the addition of Ozurdex® to bevacizumab (Avastin®) eye injections reduces the need for repeat bevacizumab eye injections in patients with nonischemic central retina vein occlusion.

      Conditions
      Non-Ischemic Central Retinal Vein Occlusion
      Talk to us